P
Parastoo Hajian
Researcher at Shahid Beheshti University of Medical Sciences and Health Services
Publications - 19
Citations - 174
Parastoo Hajian is an academic researcher from Shahid Beheshti University of Medical Sciences and Health Services. The author has contributed to research in topics: Breast cancer & Cancer. The author has an hindex of 6, co-authored 17 publications receiving 121 citations.
Papers
More filters
Journal ArticleDOI
Violence against women by their intimate partners in Shahroud in northeastern region of Iran.
TL;DR: Some socioeconomic characteristics such as educational level, occupational status of men, heavy smoking and drug abusing are associated with the occurrence of violence against one’s intimate partner.
Journal ArticleDOI
A Raman-based serum constituents' analysis for gastric cancer diagnosis: In vitro study.
Maryam Bahreini,Ahmad Hosseinzadegan,Arian Rashidi,Seyed Rouhollah Miri,Hamid Reza Mirzaei,Parastoo Hajian +5 more
TL;DR: Preliminary results can confirm the Raman method in analysis of serum and also as a diagnostic tool in screening of gastric cancer.
Journal ArticleDOI
The efficacy of Radachlorin-mediated photodynamic therapy in human hepatocellular carcinoma cells.
Hamid Reza Mirzaei,Gholamreza Esmaeeli Djavid,Mahnaz Hadizadeh,Maryam Jahanshiri-Moghadam,Parastoo Hajian +4 more
TL;DR: The in vitro data suggest that the use of PDT with Radachlorin can be effective in the treatment of HCC and showed that apoptosis is induced in HepG2 cells following Radchlorin-PDT.
Journal ArticleDOI
A Comparative Study of Survival Rate in High Grade Glioma Tumors Being Treated by Radiotherapy Alone Versus Chemoradiation With Nitrosourea.
TL;DR: It is concluded that age was the only effective factor in the survival of the patients and that chemotherapy had no significant effect on the survival on the patients.
Journal ArticleDOI
Evaluation of Silibinin Effects on the Viability of HepG2 (Human hepatocellular liver carcinoma) and HUVEC (Human Umbilical Vein Endothelial) Cell Lines.
TL;DR: The results showed that silibinin has dose-dependent inhibitory effect on the viability of HepG2 and HUVEC cells, however, Silib inin causes a more continuous dose- dependent cytotoxicity in HepG 2 cells compared to the HUV EC cells in which some degrees of resistance is apparent at the beginning.